Decoy Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $59.3M | $22.5M |
| FY2017 | — | $-2.9M | $19.2M |
| FY2018 | — | $-1.3M | $3.2M |
| FY2019 | — | $10.6M | $3.7M |
| FY2020 | — | $22.2M | $11.1M |
| FY2021 | — | $38.7M | $29.2M |
| FY2022 | — | $10.4M | $12.1M |
| FY2023 | — | $5.3M | $5.9M |
| FY2024 | — | $1.5M | $2.4M |
| FY2025 | — | $5.9M | $10.7M |